Patients who have a poor metabolism phenotype will have:
A) Slowed metabolism of a prodrug into an active drug, leading to accumulation of prodrug
B) Accumulation of inactive metabolites of drugs
C) A need for increased dosages of medications
D) Increased elimination of an active drug
Correct Answer:
Verified
Q2: Rifampin is a nonspecific CYP450 inducer that
Q3: Genetic polymorphisms account for differences in metabolism,
Q4: Up to 21% of Asians are ultra-rapid
Q5: Carbamazepine has a Black Box Warning recommending
Q6: Pharmacogenetic testing is required by the U.S.
Q7: A provider may consider testing for CYP2D6
Q9: A genetic variation in how the metabolite
Q10: Ultra-rapid metabolizers of drugs may have:
A) To
Q11: Warfarin resistance may be seen in patients
Q12: Inhibition of P-glycoprotein by a drug such
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents